Trastuzumab and dehydration Patient Reports February 09, 2010

Trastuzumab Side Effects Report #5526065-1
Trastuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 08, 2007. Female patient, 41 years of age, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, febrile neutropenia, nausea . Trastuzumab dosage: 8 MG/KG, SINGLE. During the same period patient was treated with CAPECITABINE, VINORELBINE. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5565133-5
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Dec 05, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, infection . Trastuzumab dosage: 4 MG/KG, 1/WEEK. During the same period patient was treated with PACLITAXEL, LAPATINIB, ALPRAZOLAM, VALSARTAN, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5603081-2
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Jan 11, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, infection . Trastuzumab dosage: 4 MG/KG, 1/WEEK. During the same period patient was treated with PACLITAXEL, LAPATINIB, ALPRAZOLAM, VALSARTAN, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5614458-3
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Jan 21, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: blood potassium decreased, blood urea increased, bone pain, dehydration, fatigue, guillain-barre syndrome , hypotension, lethargy. Trastuzumab dosage: 4 MG/KG, 1/WEEK. During the same period patient was treated with PACLITAXEL, LAPATINIB, HYDROCHLOROTHIAZIDE, LOPERAMIDE HYDROCHLORIDE, PERCOCET, TELMISARTAN, TEMAZEPAM, ZOLEDRONIC ACID. Patient was hospitalized. Patient recovered.


Trastuzumab Side Effects Report #5852709-0
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Aug 08, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: dehydration, guillain-barre syndrome . Trastuzumab dosage: 4 MG/KG, 1/WEEK. During the same period patient was treated with PACLITAXEL, LAPATINIB, HYDROCHLOROTHIAZIDE, LOPERAMIDE HYDROCHLORIDE, PERCOCET, TELMISARTAN, TEMAZEPAM, ZOLEDRONIC ACID. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #5979344-8
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Nov 20, 2008. Female patient was diagnosed with breast cancer  and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: anaemia, bacteraemia, dehydration, renal failure, thrombocytopenia. Trastuzumab dosage: 8 MG/KG, SINGLE. During the same period patient was treated with DOCETAXEL, CARBOPLATIN, CELEBREX, METOPROLOL TARTRATE, GLUCOSAMINE, NASAREL, FISH OIL. Patient was hospitalized. Patient recovered.

Trastuzumab Side Effects Report #6068775-6
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Jan 22, 2009. Female patient was diagnosed with breast cancer  and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: asthenia, blood calcium decreased, blood glucose increased, blood potassium decreased, blood sodium decreased, dehydration, diarrhoea, febrile neutropenia, ileus. Trastuzumab dosage: 8 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, FERROUS SULPHATE, PROMETHAZINE, PRILOSEC. Patient was hospitalized. Patient recovered.